Full Text View
Tabular View
No Study Results Posted
Related Studies
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
This study has been completed.
Study NCT00642915   Information provided by Sanofi

First Received on March 19, 2008.   Last Updated on August 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Lantus, Amaryl
Additional drug interventions recognized in this trial
Glargine
Glimepiride
Hypoglycemic Agents
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Cardiovascular Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services